Akers Biosciences Net Income

Akers Biosciences (AKER) currently reports a net income of $-20M as of December 2020. That compares with $-11M in the prior-year period — down 84.5% year over year. That is below the Healthcare sector average of $17B. Use the charts on this page to explore Akers Biosciences's net income history and peer comparisons.

Akers Biosciences's net income decreased from $-11M to $-20M — a 84.5% year-over-year decrease (period ending December 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Akers Biosciences's net income of $-20M is lower than the Healthcare sector average of $17B. That is roughly 100.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Akers Biosciences reported $-20M in net income as of December 2020. That compares with $-11M in the prior-year period — down 84.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-20M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $17B. From there, open related valuation or income-statement pages for Akers Biosciences, and consider following AKER for alerts when major investors trade the stock.